Daclatasvir Interactions
There are 267 drugs known to interact with daclatasvir, along with 1 disease interaction. Of the total drug interactions, 61 are major, 200 are moderate, and 6 are minor.
- View all 267 medications that may interact with daclatasvir
- View daclatasvir disease interactions (1)
Most frequently checked interactions
View interaction reports for daclatasvir and the medicines listed below.
- Acetylsalicylic Acid (aspirin)
- Activated Charcoal (charcoal)
- Adacel (Tdap) (diphtheria toxoid / pertussis, acellular / tetanus toxoid)
- Aspirin Low Strength (aspirin)
- Augmentin (amoxicillin / clavulanate)
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Benadryl (diphenhydramine)
- Celebrex (celecoxib)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Copper (copper gluconate)
- Cosentyx (secukinumab)
- Cozaar (losartan)
- Dextrose (glucose)
- Diltiazem Hydrochloride SR (diltiazem)
- Diprosone (betamethasone topical)
- Elemental Iron (carbonyl iron)
- Entresto (sacubitril / valsartan)
- EPA Fish Oil (omega-3 polyunsaturated fatty acids)
- Fentanyl Transdermal System (fentanyl)
- Flexeril (cyclobenzaprine)
- Glucosamine & Chondroitin with MSM (chondroitin / glucosamine / methylsulfonylmethane)
- Glycerol (glycerin)
- Humira (adalimumab)
- Iodides (sodium iodide)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Norvasc (amlodipine)
- Paracetamol (acetaminophen)
- Valproate Sodium (valproic acid)
Daclatasvir disease interactions
There is 1 disease interaction with daclatasvir which include:
More about daclatasvir
- daclatasvir consumer information
- Compare alternatives
- Reviews (10)
- Side effects
- Dosage information
- During pregnancy
- Drug class: NS5A inhibitors
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.